Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network ( TRANSNET )
dc.contributor.author | Kauffman, C.A. | en_US |
dc.contributor.author | Freifeld, A.G. | en_US |
dc.contributor.author | Andes, D.R. | en_US |
dc.contributor.author | Baddley, J.W. | en_US |
dc.contributor.author | Herwaldt, L. | en_US |
dc.contributor.author | Walker, R.C. | en_US |
dc.contributor.author | Alexander, B.D. | en_US |
dc.contributor.author | Anaissie, E.J. | en_US |
dc.contributor.author | Benedict, K. | en_US |
dc.contributor.author | Ito, J.I. | en_US |
dc.contributor.author | Knapp, K.M. | en_US |
dc.contributor.author | Lyon, G.M. | en_US |
dc.contributor.author | Marr, K.A. | en_US |
dc.contributor.author | Morrison, V.A. | en_US |
dc.contributor.author | Park, B.J. | en_US |
dc.contributor.author | Patterson, T.F. | en_US |
dc.contributor.author | Schuster, M.G. | en_US |
dc.contributor.author | Chiller, T.M. | en_US |
dc.contributor.author | Pappas, P.G. | en_US |
dc.date.accessioned | 2014-05-23T15:59:58Z | |
dc.date.available | 2015-06-01T15:48:46Z | en_US |
dc.date.issued | 2014-04 | en_US |
dc.identifier.citation | Kauffman, C.A.; Freifeld, A.G.; Andes, D.R.; Baddley, J.W.; Herwaldt, L.; Walker, R.C.; Alexander, B.D.; Anaissie, E.J.; Benedict, K.; Ito, J.I.; Knapp, K.M.; Lyon, G.M.; Marr, K.A.; Morrison, V.A.; Park, B.J.; Patterson, T.F.; Schuster, M.G.; Chiller, T.M.; Pappas, P.G. (2014). "Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network ( TRANSNET )." Transplant Infectious Disease 16(2): 213-224. | en_US |
dc.identifier.issn | 1398-2273 | en_US |
dc.identifier.issn | 1399-3062 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/106980 | |
dc.description.abstract | Background Invasive fungal infections are a major cause of morbidity and mortality among solid organ transplant ( SOT ) and hematopoietic cell transplant ( HCT ) recipients, but few data have been reported on the epidemiology of endemic fungal infections in these populations. Methods Fifteen institutions belonging to the Transplant‐Associated Infection Surveillance Network prospectively enrolled SOT and HCT recipients with histoplasmosis, blastomycosis, or coccidioidomycosis occurring between March 2001 and March 2006. Results A total of 70 patients (64 SOT recipients and 6 HCT recipients) had infection with an endemic mycosis, including 52 with histoplasmosis, 9 with blastomycosis, and 9 with coccidioidomycosis. The 12‐month cumulative incidence rate among SOT recipients for histoplasmosis was 0.102%. Occurrence of infection was bimodal; 28 (40%) infections occurred in the first 6 months post transplantation, and 24 (34%) occurred between 2 and 11 years post transplantation. Three patients were documented to have acquired infection from the donor organ. Seven SOT recipients with histoplasmosis and 3 with coccidioidomycosis died (16%); no HCT recipient died. Conclusions This 5‐year multicenter prospective surveillance study found that endemic mycoses occur uncommonly in SOT and HCT recipients, and that the period at risk extends for years after transplantation. | en_US |
dc.publisher | Lippincott, Williams, and Wilkins | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Solid Organ Transplant | en_US |
dc.subject.other | Coccidioidomycosis | en_US |
dc.subject.other | Blastomycosis | en_US |
dc.subject.other | Histoplasmosis | en_US |
dc.subject.other | Hematopoietic Cell Transplant | en_US |
dc.title | Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant‐Associated Infection Surveillance Network ( TRANSNET ) | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Microbiology and Immunology | en_US |
dc.subject.hlbsecondlevel | Medicine (General) | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/106980/1/tid12186.pdf | |
dc.identifier.doi | 10.1111/tid.12186 | en_US |
dc.identifier.source | Transplant Infectious Disease | en_US |
dc.identifier.citedreference | Pappas PG, Alexander BD, Andes DR, et al. Invasive fungal infections among organ transplant recipients in the United States: results of the Transplant‐Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010; 50: 1101 – 1112. | en_US |
dc.identifier.citedreference | Park BJ, Pappas PG, Wannemuehler KA, et al. Invasive non‐ Aspergillus mold infections in transplant recipients, United States, 2001–2006. Emerg Infect Dis 2011; 17: 1855 – 1864. | en_US |
dc.identifier.citedreference | Kontoyiannis DP, Marr KA, Park BJ, et al. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001–2006: overview of the TRANSNET database. Clin Infect Dis 2010; 50: 1091 – 1100. | en_US |
dc.identifier.citedreference | Kauffman CA. Endemic mycoses after hematopoietic stem cell or solid organ transplantation. In: Bowden R, Ljungman P, Snydman DR (eds). Transplant Infections, 3rd edn. Philadelphia, PA: Lippincott, Williams, and Wilkins, 2010: 607 – 616. | en_US |
dc.identifier.citedreference | Freifeld A, Proia LA, Andes D, et al. Voriconazole use for endemic fungal infections. Antimicrob Agents Chemother 2009; 53: 1648 – 1651. | en_US |
dc.identifier.citedreference | Johnson PC, Wheat LJ, Cloud GA, et al. Safety and efficacy of liposomal amphotericin B compared with conventional amphotericin B for induction therapy of histoplasmosis in patients with AIDS. Ann Intern Med 2002; 137: 105 – 109. | en_US |
dc.identifier.citedreference | Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis 2005; 41: 1217 – 1223. | en_US |
dc.identifier.citedreference | Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guidelines for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis 2007; 45: 807 – 817. | en_US |
dc.identifier.citedreference | Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of patients with blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 1801 – 1812. | en_US |
dc.identifier.citedreference | Antony SJ, Dummer SJ, McNeil KK, Salas I. Coccidioidomycosis in renal transplant recipients. Infect Dis Clin Pract 2005; 13: 250 – 254. | en_US |
dc.identifier.citedreference | Limaye AP, Connolly PA, Sagar M, et al. Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000; 343: 1163 – 1166. | en_US |
dc.identifier.citedreference | Tripathy U, Yung GL, Kriett JM, et al. Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002; 73: 306 – 308. | en_US |
dc.identifier.citedreference | Blodget E, Geiseler PJ, Larsen RA, Stapfer M, Qazi Y, Petrovic LM. Donor‐derived Coccidioides immitis fungemia in solid organ transplant recipients. Transpl Infect Dis 2011; 14: 305 – 310. | en_US |
dc.identifier.citedreference | Dierberg KL, Marr KA, Subramanian A, et al. Donor‐derived organ transplant transmission of coccidioidomycosis. Transpl Infect Dis 2011; 14: 300 – 304. | en_US |
dc.identifier.citedreference | Botterel F, Romand S, Saliba F, et al. A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999; 18: 662 – 664. | en_US |
dc.identifier.citedreference | Miller MB, Hendren R, Gilligan PH. Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004; 42: 2347 – 2349. | en_US |
dc.identifier.citedreference | Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis 2001; 33: 1536 – 1544. | en_US |
dc.identifier.citedreference | Vail GM, Young RS, Wheat LJ, Filo RS, Cornetta K, Goldman M. Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002; 4: 148 – 151. | en_US |
dc.identifier.citedreference | Glenn TJ, Blair JE, Adams RH. Coccidioidomycosis in hematopoietic stem cell transplant recipients. Med Mycol 2005; 43: 705 – 710. | en_US |
dc.identifier.citedreference | Martin‐Davila P, Fortun J, Lopez‐Velez R, et al. Transmission of tropical and geographically restricted infections during solid‐organ transplantation. Clin Microbiol Rev 2008; 21: 60 – 96. | en_US |
dc.identifier.citedreference | Freifeld AG, Iwen PC, Lesiak BL, Gilroy RK, Stevens RB, Kalil AC. Histoplasmosis in solid organ transplant recipients at a large Midwestern university transplant center. Transpl Infect Dis 2005; 7: 109 – 115. | en_US |
dc.identifier.citedreference | Gauthier GM, Safdar N, Klein BS, Andes DR. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis 2007; 9: 310 – 317. | en_US |
dc.identifier.citedreference | Cuellar‐Rodriquez J, Avery RK, Lard M, et al. Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009; 49: 710 – 716. | en_US |
dc.identifier.citedreference | Wright PW, Pappagianis D, Wilson M, et al. Donor‐related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003; 37: 1265 – 1269. | en_US |
dc.identifier.citedreference | Grim S, Proia L, Miller R, et al. A multicenter study of histoplasmosis and blastomycosis after solid organ transplantation. Transpl Infect Dis 2012; 14: 17 – 23. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.